KPV

Description

KPV — Tripeptide, Alpha-MSH C-Terminal Fragment

KPV (Lysine-Proline-Valine) is a synthetic tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined KPV for its suppression of NF-kappaB signaling and cytokine release pathways in cultured immune cell models, independent of the pigmentary activity associated with larger melanocortins. Investigators have studied its antimicrobial activity against select bacterial strains in vitro, and its effects on epithelial and dermal cell signaling in cultured skin-cell models. Model systems include macrophage and keratinocyte cell lines used in cytokine-release and signal-transduction assays.

Specification

• Available sizes: 5mg · 10mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: BPC-157, TB-500, GHK-Cu, KLOW Stack

Browse: Cellular & Tissue Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.